Opus Genetics, Inc. (IRD) › Operating IncomeOpus Genetics, Inc. (IRD) — Operating IncomeAnnual figures by fiscal year, from SEC filings.2009: -$6.47M2010: -$10.31M2011: -$16.13M2012: -$6.58M2013: -$7.98M2014: -$13.27M2015: -$18.26M2016: -$16.41M2017: -$17.35M2018: -$20.54M2019: -$4.19M2020: -$19.97M2021: -$22.70M2022: $18.23M2023: -$10.56M2024: -$62.07M2025: -$38.60M-$38.60M2009Operating Income (USD)2025Fiscal YearOperating IncomeChange YoY2025-$38.60M+37.8%2024-$62.07M-487.7%2023-$10.56M-158.0%2022$18.23M+180.3%2021-$22.70M-13.7%2020-$19.97M-376.2%2019-$4.19M+79.6%2018-$20.54M-18.3%2017-$17.35M-5.7%2016-$16.41M+10.1%2015-$18.26M-37.6%2014-$13.27M-66.3%2013-$7.98M-21.3%2012-$6.58M+59.2%2011-$16.13M-56.5%2010-$10.31M-59.4%2009-$6.47M—Other metrics: RevenueCost of RevenueGross ProfitNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share